SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-019015
Filing Date
2023-11-14
Accepted
2023-11-14 16:05:46
Documents
121
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aytu-20230930x10q.htm   iXBRL 10-Q 1603380
2 EX-31.1 aytu-20230930xex31d1.htm EX-31.1 15237
3 EX-31.2 aytu-20230930xex31d2.htm EX-31.2 14037
4 EX-32.1 aytu-20230930xex32d1.htm EX-32.1 14774
5 GRAPHIC aytu-20230930x10q001.jpg GRAPHIC 3651
  Complete submission text file 0001558370-23-019015.txt   10038558

Data Files

Seq Description Document Type Size
6 EX-101.SCH aytu-20230930.xsd EX-101.SCH 97081
7 EX-101.CAL aytu-20230930_cal.xml EX-101.CAL 79486
8 EX-101.DEF aytu-20230930_def.xml EX-101.DEF 328266
9 EX-101.LAB aytu-20230930_lab.xml EX-101.LAB 704172
10 EX-101.PRE aytu-20230930_pre.xml EX-101.PRE 594696
115 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20230930x10q_htm.xml XML 1894532
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 231405923
SIC: 2834 Pharmaceutical Preparations